March 2026 monthly summary for hartwigmedical/actin. Delivered targeted taxonomy updates and a datamodel upgrade to support expanded medication categorization, introduced PD-1/PD-L1 antibody drug mapping, and fixed a critical README resource link to improve onboarding. These changes enhance data integrity, broaden drug type coverage, and enable richer analytics downstream, laying groundwork for upcoming features.

February 2026 (2026-02) — Hartwig Actin: Key feature delivery focused on documentation quality to support safe and efficient patient evaluations. Major update: Patient Evaluation Documentation Improvement — README now clearly defines evaluation criteria for electrolyte levels and hormones, aligning guidance with clinical practice and reducing interpretation errors. This work enhances clinician onboarding, standardizes assessment criteria, and improves patient safety through clearer documentation. Major bugs fixed: none recorded in the provided data; emphasis this month was on documentation enhancements with traceable commits.

Concise monthly summary for 2025-12: Focused on documentation quality and terminology consistency in the hartwigmedical/actin repository. Delivered a targeted README update to correct the treatment history criterion naming from HAD_HAD_LIVER_RESECTION to HAS_HAD_LIVER_RESECTION, aligning with standard terminology and improving downstream data usage. The change was tracked with a minimal, auditable commit, reinforcing maintainability without code changes.

Month: 2025-11 — Performance-review oriented monthly summary for hartwigmedical/scripts focusing on reliability, data accuracy, and maintainability.

September 2025 monthly work summary for hartwigmedical/actin focused on reinforcing gender data handling across the platform to improve data quality, reporting accuracy, and maintainability. Delivered key gender-related fixes and enhancements across models, evaluation logic, and reporting, with emphasis on data consistency and clear presentation in outputs.

2025-08 monthly summary for hartwigmedical/scripts focused on delivering core features to advance Actin molecular interpretation and trial curation, plus multi-patient reporting. Key outcomes include: automated ACTIN trial curation, panel specifications support with a toggle for combined profiles efficacy evidence, and multi-patient personalized regression reports. No explicit bug fixes were documented in this period; temporary configuration changes supported feature rollout. Demonstrated capabilities in Bash scripting, automation pipelines, integration with LLM providers and conda environments, and contributions toward scalable data processing and reporting that drive efficiency and data-driven insights for Actin analyses.

June 2025 monthly summary: Delivered automation and documentation improvements across Actin and Scripts repos, enhancing data quality, deployment reliability, and onboarding velocity. Highlights include a documentation update for cardiac function rules, an automated trial data curation workflow, robust cloud-based data ingestion safeguards, and corrected production environment naming to reduce deployment risk. These efforts translate to clearer expectations, faster data preparation, and safer production configurations.

May 2025 monthly summary for hartwigmedical/scripts: stability, data coverage, and tooling improvements delivered to production. Focused on improving cohort mapping resolution, expanding comparison data coverage, and upgrading the served tooling to 8.3.2.

April 2025 monthly focus: delivered end-to-end SERVE upgrades, improved data comparison and integration, upgraded core tooling, and fixed stability issues across scripts and HMFTools. This work enhances deployment reliability, data fidelity, and analytics readiness for downstream products.

March 2025 performance summary covering hartwigmedical/actin and hartwigmedical/scripts. Delivered log readability improvement for activation mutation reporting, updated documentation and guidance, and updated the SAGE script to use the correct BQR loading parameter for compatibility with newer SAGE versions. These changes enhance diagnosability, documentation quality, and pipeline reliability, delivering clear business value and supporting future development.

February 2025 monthly summary highlights across hartwigmedical/scripts and hartwigmedical/actin. Delivered foundational tooling upgrades, data integration improvements, and portability refinements that improve deployment reliability, data quality, and maintainability. Focused on business value through end-to-end data processing enhancements and robust tooling.

December 2024 monthly summary: Delivered end-to-end clinical data ingestion enhancements and infrastructure improvements across Actin and Scripts repositories, enabling richer drug-interaction and QT prolongation coverage, automated pilot ingestion workflows, and reliable data synchronization to data VMs and cloud storage. Implemented new configuration options and dedicated DB classes for ingestion, automated pilot scripts to reduce manual steps, upgraded service dependencies, and introduced automated asset uploads. A notable bug fix reverted ATC-based matching in HasPotentialUncontrolledTumorRelatedPain to string matching for stability.

In 2024-11, delivered clear, business-driven improvements across two repositories, focusing on documentation quality, data robustness, and version-aligned tooling. For actin, expanded the scope of gene expression rules and drug interaction coverage by renaming rules to general terms and broadening documentation to include BCRP, P-gp, OATP1B1, and OATP1B3 in addition to CYP enzymes. For scripts, hardened the SERVE data comparison workflow: standardized gender criteria, managed optional fields for robust comparisons, and improved data consistency across SERVE database comparisons. Also aligned tooling with SERVE v7.0.0 by updating scripts to pull all JSONs, adopting a generic serve.json, and updating paths. Overall, these changes enhance accuracy, maintainability, and business value through clearer guidance, more reliable comparisons, and smoother upgrades to newer SERVE versions.